Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Recruiting1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04119024Phase 1Recruiting
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Acral MelanomaAdrenocortical CarcinomaBreast Cancer+14 more
PrincipalinvestigatorStart date: 2025-10-07
NCT03425461Phase 1Terminated
Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma
Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7+3 more
PrincipalinvestigatorStart date: 2018-06-14

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Allison Betof Warner, MD, PhD

Stanford University

Very Similar
1 trials

Shared therapeutic areas:

Acral MelanomaAdrenocortical CarcinomaBreast Cancer+14 more

Worked with same sponsors:

Anusha KalbasiCalifornia Institute for Regenerative Medicine (CIRM)+3 more
Collaborated on 1 trial
Similarity Score174%

Yan Xing, MD, PhD

City of Hope Medical Center

Very Similar
1 trials

Shared therapeutic areas:

Acral MelanomaAdrenocortical CarcinomaBreast Cancer+14 more

Worked with same sponsors:

Anusha KalbasiCalifornia Institute for Regenerative Medicine (CIRM)+3 more
Collaborated on 1 trial
Similarity Score174%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic MelanomaBreast CancerNeuroendocrine Tumors

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Uveal MelanomaAdrenocortical CarcinomaBreast Cancer

Worked with same sponsors:

Bristol-Myers SquibbNational Cancer Institute (NCI)
Similarity Score4%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Thyroid CarcinomaPancreatic Neuroendocrine Tumor
Similarity Score3%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Breast CancerNeuroendocrine Tumors
Similarity Score3%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Metastatic Malignant Solid NeoplasmMetastatic Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Breast CancerNeuroendocrine Tumors
Similarity Score3%

David S Schrump, M.D.

National Cancer Institute (NCI)

Related
21 trials

Shared therapeutic areas:

Breast CancerMetastatic Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Breast CancerMetastatic Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04119024Phase 1PrincipalInvestigator

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Acral MelanomaAdrenocortical CarcinomaBreast Cancer+14 more
Recruiting
NCT03425461Phase 1PrincipalInvestigator

Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma

Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7+3 more
Terminated

All 2 trials loaded